As on :
29-Apr-26 07:32
Net profit of Sanofi India declined 14.14% to Rs 102.60 crore in the quarter ended March 2026 as against Rs 119.50 crore during the previous quarter ended March 2025. Sales declined 11.87% to Rs 472.30 crore in the quarter ended March 2026 as against Rs 535.90 crore during the previous quarter ended March 2025.
| Particulars | Quarter Ended |
| Mar. 2026 | Mar. 2025 | % Var. |
| Sales | 472.30 | 535.90 | -12 |
| OPM % | 30.24 | 32.08 | - |
| PBDT | 146.90 | 174.90 | -16 |
| PBT | 137.90 | 165.30 | -17 |
| NP | 102.60 | 119.50 | -14 |
Powered by Capital Market - Live News
